Literature DB >> 25447206

The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.

Yan Chen1, Lei Meng1, Qiqi Yu1, Difei Dong1, Guixiang Tan1, Xiaoqin Huang2, Yongjun Tan3.   

Abstract

Transcription factor FOXM1 plays a critical role in maintenance of stem cell pluripotency through stimulating the transcription of pluripotency-related genes in mouse pluripotent stem cells. In this study, we have found that the repression of FOXM1 expression is mediated by FOXM1 3'UTR during retinoic acid-induced differentiation of human pluripotent NT2/D1 embryonal carcinoma cells. FOXM1 3'UTR contains a microRNA response element (MRE) for miR-134, which has been shown to attenuate the expression of pluripotency-related genes post-transcriptionally during mouse embryonic stem cell differentiation. We have determined that miR-134 is induced during RA-induced differentiation of NT2/D1 cells and the overexpression of miR-134 represses the expression of FOXM1 protein but not FOXM1 mRNA. Furthermore, the expression of OCT4 is diminished by FOXM1 knockdown and the OCT4 promoter is regulated directly by FOXM1, suggesting that FOXM1 is required for maintaining the expression of OCT4 in NT2/D1 cells. Together, our results suggest that FOXM1 is essential for human pluripotent stem cells and miR-134 attenuates its expression during differentiation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FOXM1 transcription factor; Pluripotent NT2/D1 embryonal carcinoma (EC) cells; Retinoic acid-induced differentiation; miR-134

Mesh:

Substances:

Year:  2014        PMID: 25447206     DOI: 10.1016/j.yexcr.2014.10.022

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Retinoic acid and microRNA.

Authors:  Lijun Wang; Atharva Piyush Rohatgi; Yu-Jui Yvonne Wan
Journal:  Methods Enzymol       Date:  2020-03-28       Impact factor: 1.600

2.  Inhibition of miR-134 Protects Against Hydrogen Peroxide-Induced Apoptosis in Retinal Ganglion Cells.

Authors:  Yi Shao; Yao Yu; Qiong Zhou; Cheng Li; Lu Yang; Chong-Gang Pei
Journal:  J Mol Neurosci       Date:  2015-03-06       Impact factor: 3.444

3.  miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.

Authors:  Qin Qin; Furong Wei; Jianbo Zhang; Xingwu Wang; Baosheng Li
Journal:  J Cell Mol Med       Date:  2016-05-31       Impact factor: 5.310

4.  Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1.

Authors:  Cheng-Cao Sun; Shu-Jun Li; De-Jia Li
Journal:  Oncotarget       Date:  2016-06-14

5.  Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis.

Authors:  Hao Liu; Ying Song; Huishi Qiu; Yanzhen Liu; Kai Luo; Yanmei Yi; Guanmin Jiang; Minying Lu; Zhijie Zhang; Jiang Yin; Shanshan Zeng; Xiangzhou Chen; Min Deng; Xiaoting Jia; Yixue Gu; Danyang Chen; Guopei Zheng; Zhimin He
Journal:  Cell Death Differ       Date:  2019-07-11       Impact factor: 15.828

Review 6.  FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer.

Authors:  Cassie Liu; Carter J Barger; Adam R Karpf
Journal:  Cancers (Basel)       Date:  2021-06-19       Impact factor: 6.639

7.  Identification of β-Dystrobrevin as a Direct Target of miR-143: Involvement in Early Stages of Neural Differentiation.

Authors:  Maria Teresa Quaranta; Isabella Spinello; Rosa Paolillo; Gianfranco Macchia; Alessandra Boe; Marina Ceccarini; Catherine Labbaye; Pompeo Macioce
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

Review 8.  FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways.

Authors:  Fergal C Kelleher; Hazel O'Sullivan
Journal:  Oncotarget       Date:  2016-07-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.